CHF75.20
1.08% yesterday
SIX Swiss Exchange, Sep 27, 05:30 pm CET
ISIN
CH0360674466
Symbol
GALE

Galenica Stock price

CHF75.20
+2.60 3.58% 1M
+0.40 0.53% 6M
+2.45 3.37% YTD
+8.10 12.07% 1Y
+8.80 13.25% 3Y
+18.00 31.47% 5Y
+32.20 74.88% 10Y
SIX Swiss Exchange, Closing price Fri, Sep 27 2024
+0.80 1.08%
ISIN
CH0360674466
Symbol
GALE
Sector

Key metrics

Market capitalization CHF3.71b
Enterprise Value CHF4.54b
P/E (TTM) P/E ratio 20.93
EV/FCF (TTM) EV/FCF 20.82
EV/Sales (TTM) EV/Sales 1.20
P/S ratio (TTM) P/S ratio 0.98
P/B ratio (TTM) P/B ratio 2.64
Dividend yield 2.96%
Last dividend (FY23) CHF2.20
Revenue growth (TTM) Revenue growth -2.84%
Revenue (TTM) Revenue CHF3.79b
EBIT (operating result TTM) EBIT CHF203.15m
Free Cash Flow (TTM) Free Cash Flow CHF218.17m
EPS (TTM) EPS CHF3.55
P/E forward 22.12
P/S forward 0.96
EV/Sales forward 1.17
Show more

Is Galenica a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Galenica Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Galenica forecast:

2x Buy
33%
4x Hold
67%

Analyst Opinions

6 Analysts have issued a Galenica forecast:

Buy
33%
Hold
67%

Financial data from Galenica

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
3,795 3,795
3% 3%
100%
- Direct Costs 3,414 3,414
3% 3%
90%
381 381
3% 3%
10%
- Selling and Administrative Expenses 74 74
8% 8%
2%
- Research and Development Expense - -
-
-
308 308
6% 6%
8%
- Depreciation and Amortization 104 104
2% 2%
3%
EBIT (Operating Income) EBIT 203 203
8% 8%
5%
Net Profit 177 177
34% 34%
5%

In millions CHF.

Don't miss a Thing! We will send you all news about Galenica directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galenica Stock News

EQS
about 2 months ago
Als weitere Anpassung fasst Galenica den Grossteil der Netzwerkpartner per 1. September 2024 in der Einheit «Products & Home Care» unter der Leitung von Thomas Szuran zusammen. Im Vordergrund steht die fokussierte Weiterentwicklung der strategischen Wachstumsfelder «Products & Brands» sowie «Home...
EQS
about 2 months ago
Der ausgewiesene EBIT erhöhte sich um 10.7% auf CHF 102.4 Mio. Der adjustierte1 EBIT der Galenica Gruppe, also ohne die Einflüsse der Accounting-Standards IFRS 16 (Leasing) und IAS 19 (Personalvorsorge), erhöhte sich um 9.9% auf CHF 99.1 Mio. Im Vorjahr war das Ergebnis durch Sonderfaktoren in Hö...
EQS
2 months ago
Im Rahmen der strategischen Partnerschaft zwischen Galenica und Redcare Pharmacy mit der Gründung des Joint Ventures Mediservice hält Galenica seit Mai 2023 eine Beteiligung von 7.9% an Redcare Pharmacy. Mit dem Ausbau der Beteiligung stärkt Galenica die Kooperation mit Redcare Pharmacy, die sich...
More Galenica News

Company Profile

Galenica AG engages as a health care provider in Switzerland. It operates through the following segments: Health & Beauty and Services. The Health and Beauty segment comprises the two business sectors Retail; and Products and Brands. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company was founded on 1927 and is headquartered in Bern, Switzerland.

Head office Switzerland
CEO Marc Werner
Employees 5,907
Founded 1927
Website www.galenica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today